Scheda del titolo · trimestre archiviato
BBIO
BridgeBio Pharma, Inc. · Healthcare · Biotechnology
19Holder monitorati
-1Δ titolari
71.67MQuote detenute
$3.72BValore dichiarato
+0Nuove posizioni
−2Uscite
Input di momentum (manager comparabili):
ampiezza dei detentori -5.0% ·
flusso azionario -1.6% ·
nuove posizioni nette -10.5%
— formula
Distribuzione diffusa — azioni in calo e minor numero di detentori
Tutte le cifre di proprietà: solo gestori 13F monitorati, posizioni in azioni ordinarie, periodo di riferimento Q3 2025
Proprietà nel tempo
| Trimestre | Detentori | Δ | Quote | Valore dichiarato | Nuovo | Uscite |
|---|---|---|---|---|---|---|
| Q2 2026 | 134 | +3 | 120.77M | $8.70B | +10 | −6 |
| Q1 2026 | 133 | +3 | 129.51M | $9.40B | +8 | −6 |
| Q4 2025 | 129 | +2 | 135.35M | $9.88B | +4 | −1 |
| Q3 2025 | 19 | -1 | 71.67M | $3.72B | — | −2 |
| Q2 2025 | 18 | -1 | 70.97M | $3.06B | +1 | −2 |
| Q1 2025 | 16 | +3 | 40.50M | $1.40B | +3 | — |
| Q4 2024 | 13 | 0 | 40.68M | $1.12B | +1 | −1 |
| Q3 2024 | 12 | -1 | 35.94M | $914.95M | — | −1 |
| Q2 2024 | 13 | — | 36.42M | $922.50M | — | — |
Chi lo detiene · Q3 2025
| # | Gestore | Quote | Δ azioni | Valore | Il loro peso | Detenuto | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passivo) | 16.83M | +2.1% | $874.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passivo) | 16.83M | +2.1% | $874.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passivo) | 16.83M | +2.1% | $874.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passivo) | 16.83M | +2.1% | $874.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | The Vanguard Group ✦ (passivo) | 16.83M | +2.1% | $874.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Viking Global Investors ✦ | 15.98M | -13.9% | $829.89M | 2.2% | ▼ Trim | 6 | SEC ↗ |
| 7 | BlackRock ✦ (passivo) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passivo) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passivo) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passivo) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passivo) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | BlackRock ✦ (passivo) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (passivo) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | BlackRock ✦ (passivo) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | BlackRock ✦ (passivo) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | BlackRock ✦ (passivo) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | BlackRock ✦ (passivo) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | BlackRock ✦ (passivo) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | BlackRock ✦ (passivo) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | BlackRock ✦ (passivo) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | BlackRock ✦ (passivo) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | BlackRock ✦ (passivo) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | BlackRock ✦ (passivo) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | BlackRock ✦ (passivo) | 14.41M | +1.1% | $748.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 25 | State Street Global Advisors ✦ (passivo) | 5.61M | -4.9% | $291.19M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 26 | State Street Global Advisors ✦ (passivo) | 5.61M | -4.9% | $291.19M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 27 | Geode Capital Management ✦ (passivo) | 3.91M | +6.2% | $203.11M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 28 | Geode Capital Management ✦ (passivo) | 3.91M | +6.2% | $203.11M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 29 | Two Sigma Investments ✦ | 2.33M | -0.4% | $120.97M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 30 | D. E. Shaw & Co. ✦ | 2.25M | +8.2% | $117.01M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 31 | D. E. Shaw & Co. ✦ | 2.25M | +8.2% | $117.01M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 32 | Goldman Sachs Group ✦ | 2.21M | — | $114.74M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Goldman Sachs Group ✦ | 2.21M | — | $114.74M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Goldman Sachs Group ✦ | 2.21M | — | $114.74M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Goldman Sachs Group ✦ | 2.21M | — | $114.74M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Goldman Sachs Group ✦ | 2.21M | — | $114.74M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Fidelity (FMR) ✦ | 1.70M | -16.1% | $88.34M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 38 | Fidelity (FMR) ✦ | 1.70M | -16.1% | $88.34M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 39 | Fidelity (FMR) ✦ | 1.70M | -16.1% | $88.34M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 40 | T. Rowe Price ✦ | 1.57M | +63.1% | $81.42M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 41 | T. Rowe Price ✦ | 1.57M | +63.1% | $81.42M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 42 | Morgan Stanley ✦ | 1.05M | — | $54.79M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Morgan Stanley ✦ | 1.05M | — | $54.79M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Morgan Stanley ✦ | 1.05M | — | $54.79M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Morgan Stanley ✦ | 1.05M | — | $54.79M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Morgan Stanley ✦ | 1.05M | — | $54.79M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | Morgan Stanley ✦ | 1.05M | — | $54.79M | 0.0% | n/c | 1 | SEC ↗ |
| 48 | Morgan Stanley ✦ | 1.05M | — | $54.79M | 0.0% | n/c | 1 | SEC ↗ |
| 49 | Morgan Stanley ✦ | 1.05M | — | $54.79M | 0.0% | n/c | 1 | SEC ↗ |
| 50 | Morgan Stanley ✦ | 1.05M | — | $54.79M | 0.0% | n/c | 1 | SEC ↗ |
| 51 | Morgan Stanley ✦ | 1.05M | — | $54.79M | 0.0% | n/c | 1 | SEC ↗ |
| 52 | Wellington Management ✦ | 1.02M | +1698.5% | $52.94M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 53 | Wellington Management ✦ | 1.02M | +1698.5% | $52.94M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 54 | Wellington Management ✦ | 1.02M | +1698.5% | $52.94M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 55 | Wellington Management ✦ | 1.02M | +1698.5% | $52.94M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 56 | Wellington Management ✦ | 1.02M | +1698.5% | $52.94M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 57 | Wellington Management ✦ | 1.02M | +1698.5% | $52.94M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 58 | Wellington Management ✦ | 1.02M | +1698.5% | $52.94M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 59 | Adage Capital Partners ✦ | 944.85K | +213.5% | $49.08M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 60 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 61 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 62 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 63 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 64 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 65 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 66 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 67 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 68 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 69 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 70 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 71 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 72 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 73 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 74 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 75 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 76 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 77 | JPMorgan Chase ✦ | 588.23K | — | $30.55M | 0.0% | n/c | 1 | SEC ↗ |
| 78 | PRIMECAP Management ✦ | 576.37K | -2.1% | $29.94M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 79 | Renaissance Technologies ✦ | 322.25K | +31.0% | $16.74M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 80 | Millennium Management ✦ | 170.44K | -72.5% | $8.85M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 81 | Millennium Management ✦ | 170.44K | -72.5% | $8.85M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 82 | Marshall Wace ✦ | 101.24K | -76.0% | $5.26M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 83 | AQR Capital Management ✦ | 98.83K | -37.4% | $5.13M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 84 | AQR Capital Management ✦ | 98.83K | -37.4% | $5.13M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 85 | AQR Capital Management ✦ | 98.83K | -37.4% | $5.13M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 86 | AQR Capital Management ✦ | 98.83K | -37.4% | $5.13M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 87 | AQR Capital Management ✦ | 98.83K | -37.4% | $5.13M | 0.0% | ▼ Trim | 6 | SEC ↗ |
"Il loro peso" = la quota della posizione sul valore azionario 13F dichiarato da quel gestore — la misura di convinzione. ✦ = gestore selezionato.
Nuovi acquirenti
| Nessun nuovo acquirente tracciato questo trimestre. |
Uscito
| Norges Bank | $84.49M | era 0.0% |
| Citadel Advisors | $14.35M | era 0.0% |
Contesto di mercato completo: su TUTTI i filer 13F (dati strutturati SEC, Q1 2026): 1 detentori, 15.30K azioni, $1,136 dichiarato. Questo è un periodo diverso e più vecchio rispetto ai dati dell'universo monitorato riportati sopra e i due non vengono mai combinati.
Frequentemente co-detenuti
Cosa detengono più spesso gli altri holder monitorati di questo titolo — conteggi di proprietà condivisa, non relazioni fondamentali.
Acquisti sul mercato aperto (P)
Nessun acquisto insider sul mercato aperto nella nostra finestra di copertura.
Vendite sul mercato aperto (S)
Aug 19
Kumar Neil
Officer, Director · 8.10K az. · $679,256
Aug 19
Kumar Neil
Officer, Director · 1.80K az. · $152,436
Aug 19
Kumar Neil
Officer, Director · 100 az. · $8,565
Aug 18
Kumar Neil
Officer, Director · 17.28K az. · $1.42M
Aug 18
Kumar Neil
Officer, Director · 1.90K az. · $154,184
Aug 18
Kumar Neil
Officer, Director · 14.60K az. · $1.21M
Aug 18
Kumar Neil
Officer, Director · 1.20K az. · $100,444
Assegnazioni, esercizi e ritenute fiscali non vengono mai conteggiati come acquisti o vendite in questa sede. Metodologia
Aug 17
SC 13D/A — KKR Genetic Disorder L.P.
4.2% di classe · Visualizza la dichiarazione SEC originale ↗
Aug 03
SC 13G/A — FARALLON CAPITAL MANAGEMENT, L.L.C.
Jul 27
SC 13G/A — BlackRock, Inc.
Jul 10
SC 13D/A — VIKING GLOBAL INVESTORS LP
5.0% di classe · Visualizza la dichiarazione SEC originale ↗
May 29
SC 13G — Farallon Capital Partners, L.P.
Provenienza: Proprietà ricavata dalle posizioni in azioni ordinarie 13F analizzate (universo monitorato, set comparabili per le variazioni); righe insider dai Moduli 3/4/5; partecipazioni dagli Schedule 13D/13G; ogni filing rimanda all'originale su SEC EDGAR.
Periodo di rendicontazione: Q3 2025 ·
Metodologia ·
Ottieni questo tramite l'API